These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11481138)

  • 21. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
    Edell WS; Rupnow MF
    Manag Care Interface; 2003 May; 16(5):64-7. PubMed ID: 12789866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in clinical manifestations and outcomes among hospitalized patients with behavioral and psychological symptoms of dementia.
    Kitamura T; Kitamura M; Hino S; Tanaka N; Kurata K
    J Clin Psychiatry; 2012 Dec; 73(12):1548-54. PubMed ID: 23290328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
    Ratzoni G; Gothelf D; Brand-Gothelf A; Reidman J; Kikinzon L; Gal G; Phillip M; Apter A; Weizman R
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):337-43. PubMed ID: 11886029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
    Gomez JC; Crawford AM
    J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD; Sanger TM
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
    Shah A; Suh GH
    Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-month outcomes for patients who switched to olanzapine treatment.
    Noordsy DL; O'Keefe C; Mueser KT; Xie H
    Psychiatr Serv; 2001 Apr; 52(4):501-7. PubMed ID: 11274497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
    Eustace A; Coen R; Walsh C; Cunningham CJ; Walsh JB; Coakley D; Lawlor BA
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of behavioral and psychological symptoms of Alzheimer's disease among institution residents and memory clinic outpatients.
    Cheng TW; Chen TF; Yip PK; Hua MS; Yang CC; Chiu MJ
    Int Psychogeriatr; 2009 Dec; 21(6):1134-41. PubMed ID: 19735590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
    Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
    Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL; Street J; Masterman D; Clark WS
    Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
    Taylor DM; Wright T; Libretto SE;
    J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
    JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
    Aarsland D; Larsen JP; Lim NG; Tandberg E
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):392-4. PubMed ID: 10440017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.